Tau-associated neuropathology in ganglion cell tumours increases with patient age but appears unrelated to ApoE genotype

Neuropathology and Applied Neurobiology

Volumn 27, Issue 3, 2001, Pages 197-205

  Brat, Daniel J ^a,c   Gearing, Marla ^a   Goldthwaite, Patricia T ^b   Wainer, Bruce H ^a   Burger, Peter C ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Apolipoprotein E.; Brain tumour; Ganglion cell tumour; Neurodegeneration; Neurofibrillary tangle; Tau

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; TAU PROTEIN;

ADULT; ARGENTAFFIN CELL; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; GANGLIONEUROMA; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE CELL; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGING; APOLIPOPROTEINS E; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; GANGLIOGLIOMA; GANGLIONEUROMA; GENOTYPE; HUMANS; INFANT; MIDDLE AGED; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEUROPIL; TAU PROTEINS;

EID: 0034911946     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2001.00311.x     Document Type: Article

References (35)

1. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease
2. Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides
3. Tumours of the central nervous system
4. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
5. Apolipoprotein E epsilon4 and incidence of Alzheimer's disease in a community population of older persons
6. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins
7. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury
8. Alzheimer's disease with and without coexisting Parkinson's disease changes: Apolipoprotein E genotype and neuropathologic correlates
9. Neuronal cytoskeletal changes are an early consequence of repetitive head injury
10. Tau hyperphosphorylation in apolipoprotein E-deficient and control mice after closed head injury
11. Meningio-angiomatosis: An immunocytochemical study
12. Meningio-angiomatosis: A report of six cases with reference to the occurrence of neurofibrillary tangles
13. Neurofibrillary changes, granulovacuolar bodies and argentophilic globules observed in tuberous sclerosis
14. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
15. Ganglioglioma containing osseous tissue and neurofibrillary tangles
16. Neurofibrillary tangles, granulovacuolar degeneration and argentophilic bodies in a third ventricular tumor
17. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing
18. α-Synuclein is expressed in a variety of brain tumors showing neuronal differentiation
19. Hypothalamic gangliocytoma. Selective appearance of neurofibrillary changes, granulovacuolar degeneration, and argentophilic bodies
20. Tau in Alzheimer's disease
21. The consortium to establish a registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
22. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study
23. A human ganglioglioma containing paired helical filaments
24. Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: Relevance to Alzheimer's disease
25. Immunocytochemistry of neurofibrillary tangles in dementia pugilistica and Alzheimer's disease: Evidence for common genesis
26. Inflammation and Alzheimer's disease pathogenesis
27. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based study
28. Ganglioglioma with neurofibrillary tangles (NFT): Neoplastic NFT share antigenic determinants with NFT of Alzheimer's disease
29. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
30. Apolipoprotein E and Alzheimer disease
31. Association of apolipoprotein E polymorphism with outcome after head injury
32. Expression of human apolipoprotein E4 in neurons causes hyperphosphrylation of protein tau in the brains of transgenic mice
33. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides
34. Apolipoprotein E (apoE) peptide regulates tau phosphorylation via two different signalling pathways
35. Alzheimer neurofibrillary tangles in diseases other than senile and pre-senile dementia